The Biotech Growth Trust
The Company seeks capital appreciation through investment in the worldwide biotechnology industry.
Why invest in the Biotech Growth Trust?
View our latest Annual Report
In order to achieve its investment objective
The Biotech Growth Trust invests in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis.
Latest insight
The Biotech Growth Trust - AGM Portfolio Manager Presentation
On Thursday 16th July 2026, The Biotech Growth Trust held its Annual General Meeting, where Portfolio Manager, Geoff Hsu provided investors with an update on BIOG's recent performance and how the portfolio is postioned to try and take advantage of the current long-term opportunities accross the global biotech sector.
Share price
View share price detail
Factsheets
How to invest
The Company’s shares are traded openly on the London Stock Exchange and can be purchased through a stock broker or other financial intermediary.
£285.0m
Our Net Asset Value*
Source: Frostrow Capital LLP
*As at 31 May 2026
Register for email alerts
Read the latest Regulatory News Service (RNS) announcements from The Biotech Growth Trust.RNS email alerts
Sign up to The Biotech Growth Trust mailing list for our monthly factsheet.
Investor Disclosure Document